Results 101 to 110 of about 7,241 (205)

The fate of immune complexes in membranous nephropathy

open access: yesFrontiers in Immunology
The most characteristic feature of membranous nephropathy (MN) is the presence of subepithelial electron dense deposits and the consequential thickening of the glomerular basement membrane.
Jie Xu   +6 more
doaj   +1 more source

Idiopathic membranous nephropathy: management strategies.

open access: yes, 2009
Treatment of idiopathic membranous nephropathy is based on a 'symptomatic' therapy that includes ACE inhibitors or angiotensin II receptor antagonists, and on an 'aetiological' therapy aimed at modulating underlying immunological mechanisms.
QUAGLIA, Marco, STRATTA, Piero
core  

New susceptibility Loci associated with kidney disease in type 1 diabetes [PDF]

open access: yes, 2012
Diabetic kidney disease, or diabetic nephropathy (DN), is a major complication of diabetes and the leading cause of end-stage renal disease (ESRD) that requires dialysis treatment or kidney transplantation.
Benjamin J. Keller (135013)   +587 more
core   +1 more source

The Levels of Tumor Necrosis Factor-alpha (TNF-α G-308A) Genes and Macrophage Migration Inhibitory Factor (MIF G173C) Polymorphism in the Idiopathic Membranous Nephropathy(IMN) in Adults

open access: yes, 2018
End-stage renal disease (ESRD) is one of serious complications of idiopathic membranous nephropathy (IMN) & it was reported in about one third of patients.
Hazim K. Abdul Kareem
core   +1 more source

Idiopathic membranous nephropathy: The natural history of untreated patients

open access: yes, 1988
Idiopathic membranous nephropathy: The natural history of untreated patients. We reviewed the diagnostic features and clinical course of 140 patients with idiopathic membranous nephropathy who had their index renal biopsies performed at the Mayo Clinic ...
Wagoner, Richard D.   +7 more
core   +1 more source

Steroid Therapy in Initial Treatment of Idiopathic Membranous Nephropathy

open access: yes, 2009
Background : The introduction of renin angiotensin system blockers (RASB) might challenge the previous results of immunosuppressive therapies in idiopathic membranous nephropathy (IMN).
Ozturk, Savaş   +8 more
core  

Comparative efficacy and safety of rituximab versus cyclophosphamide with steroids in primary membranous nephropathy: a systematic review and meta-analysis

open access: yesBMC Nephrology
Background Primary membranous nephropathy (PMN) is a leading cause of nephrotic syndrome in adults. In some patients, PMN can be severe or continue to worsen even after 6 months of supportive treatment.
Fangjiao Huang   +7 more
doaj   +1 more source

Serumanti-PLA2R antibody predicted treatment outcome in idiopathic membranous nephropathy

open access: yes, 2021
Objective To explore the predictive value of serum phospholipase A2 receptor antibody in determining the efficacy of rituximab in the treatment of idiopathic membranous nephropathy(IMN).Methods From August 1,2017 to May 31,2020,a total of 120 IMN ...
Jiang Hong   +4 more
core  

Anti-phospholipase A2 Receptor-associated Membranous Nephropathy in an Adolescent Boy with HLA-B27-positive Juvenile Idiopathic Arthritis

open access: yesSaudi Journal of Kidney Diseases and Transplantation
Juvenile idiopathic arthritis is common rheumatic disease in children and adolescents, but renal involvement is uncommon. Renal involvement is mostly in the form of secondary renal amyloidosis presenting as proteinuria.
Sudeep Patel   +5 more
doaj   +1 more source

Abstracts From PVRI 2026 Dublin

open access: yes
Pulmonary Circulation, Volume 16, Issue 2, June 2026.
wiley   +1 more source

Home - About - Disclaimer - Privacy